Your search for non small cell lung cancer returned 44 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Older than 2 years remove
Drug News remove

Your search for non small cell lung cancer returned 44 results

Sort Results:

Relevant Recent
Drug News

Study Findings Support First-Line Erlotinib in NSCLC With EGFR Mutations

For patients with non-small-cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutations, erlotinib is active, and treatment beyond progression is feasible and may delay salvage therapy in selected patients, according to a study published online in JAMA Oncology.
Drug News

Toxic Skin Effects Common With EGFR-TKI Use in NSCLC

For patients with non-small-cell lung cancer, treatment with epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) is associated with skin toxic effects, according to a research letter study published online in JAMA Dermatology.
Drug News

BRAF V600 Targetable in Some Nonmelanoma Cancers

For some, but not all, nonmelanoma cancers, BRAF V600 is a targetable oncogene, with activity seen in non-small-cell lung cancer and Erdheim-Chester disease and Langerhans'-cell histiocytosis.